Technology

NanoViricides

$4.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.16 (+3.84%) Today
+$0.03 (+0.69%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NanoViricides and other stocks, options, and ETFs commission-free!

About NNVC

NanoViricides Inc., also called NanoViricides, is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT. The listed name for NNVC is NanoViricides Inc.

CEO
Anil R. Diwan
Employees
17
Headquarters
Shelton, Connecticut
Founded
2005
Market Cap
39.92M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
633.48K
High Today
$4.74
Low Today
$4.15
Open Price
$4.55
Volume
923.28K
52 Week High
$19.20
52 Week Low
$2.85

Collections

NNVC News

BenzingaJan 22

NNVC Stock Price, NanoViricides, Inc. Common Stock Stock Quotes and News

Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patie

NNVC Earnings

-$1.24
-$0.83
-$0.41
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Feb 12, Pre-Market

You May Also Like

BR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure